Answers are grounded in this paper and cite their sources.
Background/Objectives: Dry eye disease (DED) is assessed by combining patient-reported symptoms with ocular surface findings. We evaluated a deep learning strategy with qualitative post hoc explanation in two independent ophthalmic imaging tasks: DED-versus-healthy classification from anterior segment slit lamp images; and four-class recognition of tear film lipid layer (TFLL) interference patterns in Tearscope images using the Guillon categories. Methods: ResNet backbones were modified by adding parallel expansion channels while keeping the ImageNet-initialized channels frozen. The added channels were He-normal initialized and trained at 1 × 10−4, with the MLP classification head trained at 1 × 10−3. Latin hypercube sampling was used for hyperparameter selection within the development data. We used Grad-CAM and Grad-CAM++ only for post hoc interpretation. We evaluated ShECS slit lamp images (n = 434) and VOPTICAL-Is Tearscope images (n = 406). Results: Under the original evaluations, ResNet-101×3 achieved the highest scores among the evaluated configurations on both tasks. On ShECS, accuracy was 74% (95% CI: 0.63–0.82), with precision 0.80, recall 0.90, and F1-score 0.85 for the DED (positive) class, and AUC 0.80. On VOPTICAL-Is, the original image-level evaluation yielded four-class TFLL accuracy of 90% (95% CI: 0.82–0.95), with macro precision 0.89, macro recall 0.90, and macro F14 0.89, and a macro one-versus-rest AUC of 0.98. Conclusions: These preliminary proof-of-concept results support further evaluation of the combined channel-expansion and differential-training strategy, together with qualitative post hoc explanation methods for ophthalmic image classification. Because VOPTICAL-Is contains only healthy-subject images and has no documented subject identifiers in the accessed release (group-code overlap between the development and held-out subsets was observed, and subject overlap cannot be excluded), the second task represents image-level TFLL pattern classification rather than clinical DED-subtype diagnosis. A separate code-grouped sensitivity analysis with a frozen ResNet-50 feature extractor yielded 0.59 held-out accuracy (macro one-versus-rest AUC 0.85). Because this grouped run did not re-run the 0.90 ResNet-101×3 configuration, the numerical difference cannot be attributed solely to partitioning, or interpreted as a direct measurement of subject-level leakage; rather, it demonstrates sensitivity to group-aware partitioning. The original image-level estimates should therefore be treated as exploratory and not as evidence of subject-level generalization. A controlled 2 × 2 factorial ablation (channel width × trainability policy) on the same code-grouped partition, executed as a TensorFlow/Keras ResNet-50 reconstruction with three seeds per cell, indicated descriptively that unfreezing the final convolutional stage was associated with higher accuracy and macro F1 (e.g., standard width: accuracy 0.556 vs. 0.469), whereas the effect of widening was small and inconsistent across metrics and policies. These descriptive summaries involve no significance testing and do not measure subject-level leakage. External clinical validation of identified cohorts is needed before routine use.
No takes yet. Share an insight, caveat, or question.
Talebi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: